# A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease

Study · id `cardio:ct-nct01674712` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01674712](<https://clinicaltrials.gov/study/NCT01674712>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01674712

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 575 participants.

## Technical summary

Registry record NCT01674712. Randomized; quadruple masking; primary purpose treatment. Start 2012-06 (registry gives no type); primary completion 2013-10 (actual). Results posted on 2014-10-30.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 575 participants (enrolled count; ClinicalTrials.gov record NCT01674712, source copy `cardio:ctgov-nct01674712-2014-12-11`, retrieved 2026-10-31)
- Start date: 2012-06 (registry gives no type) (ClinicalTrials.gov record NCT01674712, source copy `cardio:ctgov-nct01674712-2014-12-11`, retrieved 2026-10-31)
- Primary completion: 2013-10 (actual) (ClinicalTrials.gov record NCT01674712, source copy `cardio:ctgov-nct01674712-2014-12-11`, retrieved 2026-10-31)
- Completion: 2013-10 (actual) (ClinicalTrials.gov record NCT01674712, source copy `cardio:ctgov-nct01674712-2014-12-11`, retrieved 2026-10-31)
- Results first posted: 2014-10-30 (ClinicalTrials.gov record NCT01674712, source copy `cardio:ctgov-nct01674712-2014-12-11`, retrieved 2026-10-31)
- Countries: Argentina; Czechia; Germany; Mexico; Poland; Romania; Russia (ClinicalTrials.gov record NCT01674712, source copy `cardio:ctgov-nct01674712-2014-12-11`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01674712-2014-12-11`, retrieved 2026-10-31)

## The registry's words

- Brief title: A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease
- Condition: Dyslipidemia
- Intervention (Drug): Fixed Combination of Fenofibrate/simvastatin 145/20 mg
- Intervention (Drug): Simvastatin 20 mg
- Intervention (Drug): Fenofibrate 145 mg
- Intervention (Drug): Fixed Combination of Fenofibrate/simvastatin 145/40 mg
- Intervention (Drug): Simvastatin 40 mg
- Lead sponsor: Abbott
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

## Provenance

Content hash: db4b2ea8dcfb15ef0fe978c8a151fc060eedb47b93261da7477bf86daef60657
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
